Remazolam Besylate in the Extraction of Impacted Wisdom Teeth
Status:
Not yet recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
Benzodiazepines, represented by midazolam, are often used for sedation in outpatient surgery
in stomatology. However, midazolam has the problems of slow consciousness recovery and long
recovery time, which brings trouble to the patients. Remazolam besylate is a new type of
ultra short acting sedative anesthetic. Compared with other similar products, remazolam
besylate has faster effect, rapid metabolism and has no accumulation, which may mean that
compared with midazolam, remazolam besylate has a better clinical application prospect in
outpatient surgery in stomatology.
Phase:
N/A
Details
Lead Sponsor:
Peking Union Medical College Hospital
Collaborators:
Beijing Anzhen Hospital Beijing Shijitan Hospital, Capital Medical University